Preventive Vaccines Market

1 Study Coverage
    1.1 Preventive Vaccines Product Introduction
    1.2 Market by Type
        1.2.1 Global Preventive Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Intramuscular Injection
        1.2.3 Nasal Spray
        1.2.4 Intradermal Shot
    1.3 Market by Application
        1.3.1 Global Preventive Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Preventive Vaccines Sales Estimates and Forecasts 2017-2028
    2.2 Global Preventive Vaccines Revenue Estimates and Forecasts 2017-2028
    2.3 Global Preventive Vaccines Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Preventive Vaccines Sales by Region
        2.4.1 Global Preventive Vaccines Sales by Region (2017-2022)
        2.4.2 Global Sales Preventive Vaccines by Region (2023-2028)
    2.5 Global Preventive Vaccines Revenue by Region
        2.5.1 Global Preventive Vaccines Revenue by Region (2017-2022)
        2.5.2 Global Preventive Vaccines Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Preventive Vaccines Sales by Manufacturers
        3.1.1 Global Top Preventive Vaccines Manufacturers by Sales (2017-2022)
        3.1.2 Global Preventive Vaccines Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Preventive Vaccines in 2021
    3.2 Global Preventive Vaccines Revenue by Manufacturers
        3.2.1 Global Preventive Vaccines Revenue by Manufacturers (2017-2022)
        3.2.2 Global Preventive Vaccines Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Preventive Vaccines Revenue in 2021
    3.3 Global Preventive Vaccines Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Preventive Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Preventive Vaccines Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Preventive Vaccines Sales by Type
        4.1.1 Global Preventive Vaccines Historical Sales by Type (2017-2022)
        4.1.2 Global Preventive Vaccines Forecasted Sales by Type (2023-2028)
        4.1.3 Global Preventive Vaccines Sales Market Share by Type (2017-2028)
    4.2 Global Preventive Vaccines Revenue by Type
        4.2.1 Global Preventive Vaccines Historical Revenue by Type (2017-2022)
        4.2.2 Global Preventive Vaccines Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Preventive Vaccines Revenue Market Share by Type (2017-2028)
    4.3 Global Preventive Vaccines Price by Type
        4.3.1 Global Preventive Vaccines Price by Type (2017-2022)
        4.3.2 Global Preventive Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Preventive Vaccines Sales by Application
        5.1.1 Global Preventive Vaccines Historical Sales by Application (2017-2022)
        5.1.2 Global Preventive Vaccines Forecasted Sales by Application (2023-2028)
        5.1.3 Global Preventive Vaccines Sales Market Share by Application (2017-2028)
    5.2 Global Preventive Vaccines Revenue by Application
        5.2.1 Global Preventive Vaccines Historical Revenue by Application (2017-2022)
        5.2.2 Global Preventive Vaccines Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Preventive Vaccines Revenue Market Share by Application (2017-2028)
    5.3 Global Preventive Vaccines Price by Application
        5.3.1 Global Preventive Vaccines Price by Application (2017-2022)
        5.3.2 Global Preventive Vaccines Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Preventive Vaccines Market Size by Type
        6.1.1 North America Preventive Vaccines Sales by Type (2017-2028)
        6.1.2 North America Preventive Vaccines Revenue by Type (2017-2028)
    6.2 North America Preventive Vaccines Market Size by Application
        6.2.1 North America Preventive Vaccines Sales by Application (2017-2028)
        6.2.2 North America Preventive Vaccines Revenue by Application (2017-2028)
    6.3 North America Preventive Vaccines Market Size by Country
        6.3.1 North America Preventive Vaccines Sales by Country (2017-2028)
        6.3.2 North America Preventive Vaccines Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Preventive Vaccines Market Size by Type
        7.1.1 Europe Preventive Vaccines Sales by Type (2017-2028)
        7.1.2 Europe Preventive Vaccines Revenue by Type (2017-2028)
    7.2 Europe Preventive Vaccines Market Size by Application
        7.2.1 Europe Preventive Vaccines Sales by Application (2017-2028)
        7.2.2 Europe Preventive Vaccines Revenue by Application (2017-2028)
    7.3 Europe Preventive Vaccines Market Size by Country
        7.3.1 Europe Preventive Vaccines Sales by Country (2017-2028)
        7.3.2 Europe Preventive Vaccines Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Preventive Vaccines Market Size by Type
        8.1.1 Asia Pacific Preventive Vaccines Sales by Type (2017-2028)
        8.1.2 Asia Pacific Preventive Vaccines Revenue by Type (2017-2028)
    8.2 Asia Pacific Preventive Vaccines Market Size by Application
        8.2.1 Asia Pacific Preventive Vaccines Sales by Application (2017-2028)
        8.2.2 Asia Pacific Preventive Vaccines Revenue by Application (2017-2028)
    8.3 Asia Pacific Preventive Vaccines Market Size by Region
        8.3.1 Asia Pacific Preventive Vaccines Sales by Region (2017-2028)
        8.3.2 Asia Pacific Preventive Vaccines Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Preventive Vaccines Market Size by Type
        9.1.1 Latin America Preventive Vaccines Sales by Type (2017-2028)
        9.1.2 Latin America Preventive Vaccines Revenue by Type (2017-2028)
    9.2 Latin America Preventive Vaccines Market Size by Application
        9.2.1 Latin America Preventive Vaccines Sales by Application (2017-2028)
        9.2.2 Latin America Preventive Vaccines Revenue by Application (2017-2028)
    9.3 Latin America Preventive Vaccines Market Size by Country
        9.3.1 Latin America Preventive Vaccines Sales by Country (2017-2028)
        9.3.2 Latin America Preventive Vaccines Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Preventive Vaccines Market Size by Type
        10.1.1 Middle East and Africa Preventive Vaccines Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Preventive Vaccines Revenue by Type (2017-2028)
    10.2 Middle East and Africa Preventive Vaccines Market Size by Application
        10.2.1 Middle East and Africa Preventive Vaccines Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Preventive Vaccines Revenue by Application (2017-2028)
    10.3 Middle East and Africa Preventive Vaccines Market Size by Country
        10.3.1 Middle East and Africa Preventive Vaccines Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Preventive Vaccines Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Sanofi
        11.1.1 Sanofi Corporation Information
        11.1.2 Sanofi Overview
        11.1.3 Sanofi Preventive Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Sanofi Preventive Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Sanofi Recent Developments
    11.2 AstraZeneca
        11.2.1 AstraZeneca Corporation Information
        11.2.2 AstraZeneca Overview
        11.2.3 AstraZeneca Preventive Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 AstraZeneca Preventive Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 AstraZeneca Recent Developments
    11.3 CSL Ltd
        11.3.1 CSL Ltd Corporation Information
        11.3.2 CSL Ltd Overview
        11.3.3 CSL Ltd Preventive Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 CSL Ltd Preventive Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 CSL Ltd Recent Developments
    11.4 Abbott
        11.4.1 Abbott Corporation Information
        11.4.2 Abbott Overview
        11.4.3 Abbott Preventive Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Abbott Preventive Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Abbott Recent Developments
    11.5 GlaxoSmithKline
        11.5.1 GlaxoSmithKline Corporation Information
        11.5.2 GlaxoSmithKline Overview
        11.5.3 GlaxoSmithKline Preventive Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 GlaxoSmithKline Preventive Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 GlaxoSmithKline Recent Developments
    11.6 Serum Institute of India
        11.6.1 Serum Institute of India Corporation Information
        11.6.2 Serum Institute of India Overview
        11.6.3 Serum Institute of India Preventive Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Serum Institute of India Preventive Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Serum Institute of India Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Preventive Vaccines Industry Chain Analysis
    12.2 Preventive Vaccines Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Preventive Vaccines Production Mode & Process
    12.4 Preventive Vaccines Sales and Marketing
        12.4.1 Preventive Vaccines Sales Channels
        12.4.2 Preventive Vaccines Distributors
    12.5 Preventive Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Preventive Vaccines Industry Trends
    13.2 Preventive Vaccines Market Drivers
    13.3 Preventive Vaccines Market Challenges
    13.4 Preventive Vaccines Market Restraints
14 Key Findings in The Global Preventive Vaccines Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Preventive Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Intramuscular Injection
    Table 3. Major Manufacturers of Nasal Spray
    Table 4. Major Manufacturers of Intradermal Shot
    Table 5. Global Preventive Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Preventive Vaccines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Preventive Vaccines Sales by Region (2017-2022) & (K Doses)
    Table 8. Global Preventive Vaccines Sales Market Share by Region (2017-2022)
    Table 9. Global Preventive Vaccines Sales by Region (2023-2028) & (K Doses)
    Table 10. Global Preventive Vaccines Sales Market Share by Region (2023-2028)
    Table 11. Global Preventive Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Preventive Vaccines Revenue Market Share by Region (2017-2022)
    Table 13. Global Preventive Vaccines Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Preventive Vaccines Revenue Market Share by Region (2023-2028)
    Table 15. Global Preventive Vaccines Sales by Manufacturers (2017-2022) & (K Doses)
    Table 16. Global Preventive Vaccines Sales Share by Manufacturers (2017-2022)
    Table 17. Global Preventive Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Preventive Vaccines Revenue Share by Manufacturers (2017-2022)
    Table 19. Preventive Vaccines Price by Manufacturers (2017-2022) &(USD/Doses)
    Table 20. Global Preventive Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Preventive Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preventive Vaccines as of 2021)
    Table 22. Preventive Vaccines Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Preventive Vaccines Product Offered
    Table 24. Date of Manufacturers Enter into Preventive Vaccines Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Preventive Vaccines Sales by Type (2017-2022) & (K Doses)
    Table 27. Global Preventive Vaccines Sales by Type (2023-2028) & (K Doses)
    Table 28. Global Preventive Vaccines Sales Share by Type (2017-2022)
    Table 29. Global Preventive Vaccines Sales Share by Type (2023-2028)
    Table 30. Global Preventive Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Preventive Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Preventive Vaccines Revenue Share by Type (2017-2022)
    Table 33. Global Preventive Vaccines Revenue Share by Type (2023-2028)
    Table 34. Preventive Vaccines Price by Type (2017-2022) & (USD/Doses)
    Table 35. Global Preventive Vaccines Price Forecast by Type (2023-2028) & (USD/Doses)
    Table 36. Global Preventive Vaccines Sales by Application (2017-2022) & (K Doses)
    Table 37. Global Preventive Vaccines Sales by Application (2023-2028) & (K Doses)
    Table 38. Global Preventive Vaccines Sales Share by Application (2017-2022)
    Table 39. Global Preventive Vaccines Sales Share by Application (2023-2028)
    Table 40. Global Preventive Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Preventive Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Preventive Vaccines Revenue Share by Application (2017-2022)
    Table 43. Global Preventive Vaccines Revenue Share by Application (2023-2028)
    Table 44. Preventive Vaccines Price by Application (2017-2022) & (USD/Doses)
    Table 45. Global Preventive Vaccines Price Forecast by Application (2023-2028) & (USD/Doses)
    Table 46. North America Preventive Vaccines Sales by Type (2017-2022) & (K Doses)
    Table 47. North America Preventive Vaccines Sales by Type (2023-2028) & (K Doses)
    Table 48. North America Preventive Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Preventive Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Preventive Vaccines Sales by Application (2017-2022) & (K Doses)
    Table 51. North America Preventive Vaccines Sales by Application (2023-2028) & (K Doses)
    Table 52. North America Preventive Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Preventive Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Preventive Vaccines Sales by Country (2017-2022) & (K Doses)
    Table 55. North America Preventive Vaccines Sales by Country (2023-2028) & (K Doses)
    Table 56. North America Preventive Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Preventive Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Preventive Vaccines Sales by Type (2017-2022) & (K Doses)
    Table 59. Europe Preventive Vaccines Sales by Type (2023-2028) & (K Doses)
    Table 60. Europe Preventive Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Preventive Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Preventive Vaccines Sales by Application (2017-2022) & (K Doses)
    Table 63. Europe Preventive Vaccines Sales by Application (2023-2028) & (K Doses)
    Table 64. Europe Preventive Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Preventive Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Preventive Vaccines Sales by Country (2017-2022) & (K Doses)
    Table 67. Europe Preventive Vaccines Sales by Country (2023-2028) & (K Doses)
    Table 68. Europe Preventive Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Preventive Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Preventive Vaccines Sales by Type (2017-2022) & (K Doses)
    Table 71. Asia Pacific Preventive Vaccines Sales by Type (2023-2028) & (K Doses)
    Table 72. Asia Pacific Preventive Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Preventive Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Preventive Vaccines Sales by Application (2017-2022) & (K Doses)
    Table 75. Asia Pacific Preventive Vaccines Sales by Application (2023-2028) & (K Doses)
    Table 76. Asia Pacific Preventive Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Preventive Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Preventive Vaccines Sales by Region (2017-2022) & (K Doses)
    Table 79. Asia Pacific Preventive Vaccines Sales by Region (2023-2028) & (K Doses)
    Table 80. Asia Pacific Preventive Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Preventive Vaccines Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Preventive Vaccines Sales by Type (2017-2022) & (K Doses)
    Table 83. Latin America Preventive Vaccines Sales by Type (2023-2028) & (K Doses)
    Table 84. Latin America Preventive Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Preventive Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Preventive Vaccines Sales by Application (2017-2022) & (K Doses)
    Table 87. Latin America Preventive Vaccines Sales by Application (2023-2028) & (K Doses)
    Table 88. Latin America Preventive Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Preventive Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Preventive Vaccines Sales by Country (2017-2022) & (K Doses)
    Table 91. Latin America Preventive Vaccines Sales by Country (2023-2028) & (K Doses)
    Table 92. Latin America Preventive Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Preventive Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Preventive Vaccines Sales by Type (2017-2022) & (K Doses)
    Table 95. Middle East and Africa Preventive Vaccines Sales by Type (2023-2028) & (K Doses)
    Table 96. Middle East and Africa Preventive Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Preventive Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Preventive Vaccines Sales by Application (2017-2022) & (K Doses)
    Table 99. Middle East and Africa Preventive Vaccines Sales by Application (2023-2028) & (K Doses)
    Table 100. Middle East and Africa Preventive Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Preventive Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Preventive Vaccines Sales by Country (2017-2022) & (K Doses)
    Table 103. Middle East and Africa Preventive Vaccines Sales by Country (2023-2028) & (K Doses)
    Table 104. Middle East and Africa Preventive Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Preventive Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Sanofi Corporation Information
    Table 107. Sanofi Description and Major Businesses
    Table 108. Sanofi Preventive Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 109. Sanofi Preventive Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Sanofi Recent Developments
    Table 111. AstraZeneca Corporation Information
    Table 112. AstraZeneca Description and Major Businesses
    Table 113. AstraZeneca Preventive Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 114. AstraZeneca Preventive Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. AstraZeneca Recent Developments
    Table 116. CSL Ltd Corporation Information
    Table 117. CSL Ltd Description and Major Businesses
    Table 118. CSL Ltd Preventive Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 119. CSL Ltd Preventive Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. CSL Ltd Recent Developments
    Table 121. Abbott Corporation Information
    Table 122. Abbott Description and Major Businesses
    Table 123. Abbott Preventive Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 124. Abbott Preventive Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Abbott Recent Developments
    Table 126. GlaxoSmithKline Corporation Information
    Table 127. GlaxoSmithKline Description and Major Businesses
    Table 128. GlaxoSmithKline Preventive Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 129. GlaxoSmithKline Preventive Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. GlaxoSmithKline Recent Developments
    Table 131. Serum Institute of India Corporation Information
    Table 132. Serum Institute of India Description and Major Businesses
    Table 133. Serum Institute of India Preventive Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
    Table 134. Serum Institute of India Preventive Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Serum Institute of India Recent Developments
    Table 136. Key Raw Materials Lists
    Table 137. Raw Materials Key Suppliers Lists
    Table 138. Preventive Vaccines Distributors List
    Table 139. Preventive Vaccines Customers List
    Table 140. Preventive Vaccines Market Trends
    Table 141. Preventive Vaccines Market Drivers
    Table 142. Preventive Vaccines Market Challenges
    Table 143. Preventive Vaccines Market Restraints
    Table 144. Research Programs/Design for This Report
    Table 145. Key Data Information from Secondary Sources
    Table 146. Key Data Information from Primary Sources
List of Figures
    Figure 1. Preventive Vaccines Product Picture
    Figure 3. Global Preventive Vaccines Market Share by Type in 2021 & 2028
    Figure 3. Intramuscular Injection Product Picture
    Figure 4. Nasal Spray Product Picture
    Figure 5. Intradermal Shot Product Picture
    Figure 6. Global Preventive Vaccines Market Share by Application in 2021 & 2028
    Figure 7. Hospital
    Figure 8. Clinic
    Figure 9. Other
    Figure 10. Preventive Vaccines Report Years Considered
    Figure 11. Global Preventive Vaccines Sales 2017-2028 (K Doses)
    Figure 12. Global Preventive Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Preventive Vaccines Revenue 2017-2028 (US$ Million)
    Figure 14. Global Preventive Vaccines Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 15. Global Preventive Vaccines Sales Market Share by Region (2017-2022)
    Figure 16. Global Preventive Vaccines Sales Market Share by Region (2023-2028)
    Figure 17. North America Preventive Vaccines Sales YoY (2017-2028) & (K Doses)
    Figure 18. North America Preventive Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Europe Preventive Vaccines Sales YoY (2017-2028) & (K Doses)
    Figure 20. Europe Preventive Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Asia-Pacific Preventive Vaccines Sales YoY (2017-2028) & (K Doses)
    Figure 22. Asia-Pacific Preventive Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Latin America Preventive Vaccines Sales YoY (2017-2028) & (K Doses)
    Figure 24. Latin America Preventive Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Middle East & Africa Preventive Vaccines Sales YoY (2017-2028) & (K Doses)
    Figure 26. Middle East & Africa Preventive Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. The Preventive Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 28. The Top 5 and 10 Largest Manufacturers of Preventive Vaccines in the World: Market Share by Preventive Vaccines Revenue in 2021
    Figure 29. Global Preventive Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 30. Global Preventive Vaccines Sales Market Share by Type (2017-2028)
    Figure 31. Global Preventive Vaccines Revenue Market Share by Type (2017-2028)
    Figure 32. Global Preventive Vaccines Sales Market Share by Application (2017-2028)
    Figure 33. Global Preventive Vaccines Revenue Market Share by Application (2017-2028)
    Figure 34. North America Preventive Vaccines Sales Market Share by Type (2017-2028)
    Figure 35. North America Preventive Vaccines Revenue Market Share by Type (2017-2028)
    Figure 36. North America Preventive Vaccines Sales Market Share by Application (2017-2028)
    Figure 37. North America Preventive Vaccines Revenue Market Share by Application (2017-2028)
    Figure 38. North America Preventive Vaccines Sales Share by Country (2017-2028)
    Figure 39. North America Preventive Vaccines Revenue Share by Country (2017-2028)
    Figure 40. U.S. Preventive Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 41. Canada Preventive Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 42. Europe Preventive Vaccines Sales Market Share by Type (2017-2028)
    Figure 43. Europe Preventive Vaccines Revenue Market Share by Type (2017-2028)
    Figure 44. Europe Preventive Vaccines Sales Market Share by Application (2017-2028)
    Figure 45. Europe Preventive Vaccines Revenue Market Share by Application (2017-2028)
    Figure 46. Europe Preventive Vaccines Sales Share by Country (2017-2028)
    Figure 47. Europe Preventive Vaccines Revenue Share by Country (2017-2028)
    Figure 48. Germany Preventive Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 49. France Preventive Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 50. U.K. Preventive Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 51. Italy Preventive Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 52. Russia Preventive Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 53. Asia Pacific Preventive Vaccines Sales Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Preventive Vaccines Revenue Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Preventive Vaccines Sales Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Preventive Vaccines Revenue Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Preventive Vaccines Sales Share by Region (2017-2028)
    Figure 58. Asia Pacific Preventive Vaccines Revenue Share by Region (2017-2028)
    Figure 59. China Preventive Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 60. Japan Preventive Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 61. South Korea Preventive Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 62. India Preventive Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 63. Australia Preventive Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 64. Taiwan Preventive Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 65. Indonesia Preventive Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 66. Thailand Preventive Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 67. Malaysia Preventive Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 68. Philippines Preventive Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 69. Latin America Preventive Vaccines Sales Market Share by Type (2017-2028)
    Figure 70. Latin America Preventive Vaccines Revenue Market Share by Type (2017-2028)
    Figure 71. Latin America Preventive Vaccines Sales Market Share by Application (2017-2028)
    Figure 72. Latin America Preventive Vaccines Revenue Market Share by Application (2017-2028)
    Figure 73. Latin America Preventive Vaccines Sales Share by Country (2017-2028)
    Figure 74. Latin America Preventive Vaccines Revenue Share by Country (2017-2028)
    Figure 75. Mexico Preventive Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 76. Brazil Preventive Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 77. Argentina Preventive Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 78. Middle East and Africa Preventive Vaccines Sales Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Preventive Vaccines Revenue Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Preventive Vaccines Sales Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Preventive Vaccines Revenue Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Preventive Vaccines Sales Share by Country (2017-2028)
    Figure 83. Middle East and Africa Preventive Vaccines Revenue Share by Country (2017-2028)
    Figure 84. Turkey Preventive Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 85. Saudi Arabia Preventive Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 86. U.A.E Preventive Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 87. Preventive Vaccines Value Chain
    Figure 88. Preventive Vaccines Production Process
    Figure 89. Channels of Distribution
    Figure 90. Distributors Profiles
    Figure 91. Bottom-up and Top-down Approaches for This Report
    Figure 92. Data Triangulation
    Figure 93. Key Executives Interviewed